A detailed history of Captrust Financial Advisors transactions in Boston Scientific Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 51,820 shares of BSX stock, worth $4.57 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
51,820
Previous 50,488 2.64%
Holding current value
$4.57 Million
Previous $3.46 Million 15.42%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $89,683 - $103,509
1,332 Added 2.64%
51,820 $3.99 Million
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $2.01 Million - $2.39 Million
-34,875 Reduced 40.85%
50,488 $3.46 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $494,522 - $587,754
10,167 Added 13.52%
85,363 $4.93 Million
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $1.06 Million - $1.16 Million
21,158 Added 39.15%
75,196 $3.97 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $13,573 - $14,916
273 Added 0.51%
54,038 $2.92 Million
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $283,976 - $315,088
6,298 Added 13.27%
53,765 $2.69 Million
Q4 2022

Feb 15, 2023

BUY
$39.56 - $47.22 $398,131 - $475,222
10,064 Added 26.91%
47,467 $2.2 Million
Q3 2022

Nov 16, 2022

BUY
$36.71 - $109.66 $144,931 - $432,937
3,948 Added 11.8%
37,403 $1.45 Million
Q2 2022

Aug 23, 2022

SELL
$35.24 - $47.1 $53,106 - $70,979
-1,507 Reduced 4.31%
33,455 $1.25 Million
Q2 2022

Aug 16, 2022

BUY
$35.24 - $47.1 $261,938 - $350,094
7,433 Added 27.0%
34,962 $1.3 Million
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $114,560 - $126,325
2,801 Added 11.33%
27,529 $1.22 Million
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $5,748 - $6,775
-151 Reduced 0.61%
24,728 $1.05 Million
Q3 2021

Nov 16, 2021

BUY
$41.23 - $45.88 $104,188 - $115,938
2,527 Added 11.31%
24,879 $1.08 Million
Q2 2021

Aug 16, 2021

SELL
$38.58 - $44.24 $60,686 - $69,589
-1,573 Reduced 6.57%
22,352 $956,000
Q1 2021

May 17, 2021

BUY
$35.27 - $39.67 $356,579 - $401,063
10,110 Added 73.18%
23,925 $925,000
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $47,271 - $59,849
-1,426 Reduced 9.36%
13,815 $497,000
Q3 2020

Nov 17, 2020

BUY
$34.44 - $42.23 $119,782 - $146,875
3,478 Added 29.57%
15,241 $586,000
Q2 2020

Aug 14, 2020

BUY
$30.19 - $39.11 $59,323 - $76,851
1,965 Added 20.06%
11,763 $415,000
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $80,408 - $142,295
-3,113 Reduced 24.11%
9,798 $296,000
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $140,421 - $168,231
3,708 Added 40.29%
12,911 $585,000
Q3 2019

Nov 14, 2019

BUY
$40.31 - $43.45 $20,598 - $22,202
511 Added 5.88%
9,203 $374,000
Q2 2019

Aug 13, 2019

SELL
$34.91 - $42.98 $29,464 - $36,275
-844 Reduced 8.85%
8,692 $374,000
Q1 2019

May 15, 2019

BUY
$32.91 - $40.75 $8,721 - $10,798
265 Added 2.86%
9,536 $366,000
Q4 2018

Feb 13, 2019

BUY
$31.73 - $39.04 $1,300 - $1,600
41 Added 0.44%
9,271 $328,000
Q3 2018

Nov 15, 2018

BUY
$32.83 - $38.63 $200,295 - $235,681
6,101 Added 194.98%
9,230 $355,000
Q2 2018

Aug 13, 2018

BUY
$26.84 - $34.32 $42,782 - $54,706
1,594 Added 103.84%
3,129 $102,000
Q1 2018

May 15, 2018

SELL
$25.2 - $28.54 $30,618 - $34,676
-1,215 Reduced 44.18%
1,535 $41,000
Q4 2017

Feb 14, 2018

BUY
$24.79 - $29.8 $68,172 - $81,950
2,750
2,750 $68,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $126B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.